In Vivo CAR-T Cell Therapy, How It Works
A 5-step animated schematic: from vector delivery to tumor killing inside the body
An animated schematic of in vivo CAR-T cell therapy showing how viral vectors or lipid nanoparticles deliver the CAR gene directly into T cells inside the patient's bloodstream, from injection to tumor killing.
In vivo CAR-T is an emerging next-generation alternative to traditional ex vivo manufacturing. Rather than removing and engineering T cells outside the body, this approach delivers the CAR gene directly into the patient using viral vectors or lipid nanoparticles (LNPs) reprogramming T cells inside the bloodstream. A 2025 peer-reviewed review in the Journal of Translational Medicine (Pinto et al.) confirms that in vivo T cell engineering can eliminate the complexity and cost of ex vivo manufacturing, potentially making CAR-T therapy accessible to patients who currently cannot benefit from it.
Reference: https://link.springer.com/article/10.1186/s12967-024-06052-3
Need a schematic like this?
Schematics are priced per scope. Tell us about your therapy and we will send a custom quote.
Get custom pricingSchematics start from custom-quote pricing. Standard turnaround: 15-25 days.

